Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Vibrosense Dynamics

0.59 SEK

+6.52 %

Less than 1K followers

VSD B

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+6.52 %
-23.64 %
-66.30 %
-70.60 %
+47.00 %
+45.19 %
-94.14 %
-94.02 %
-85.23 %

Vibrosense Dynamics operates in the medical technology sector. The company develops products and services for diagnostic support in nerve damage. The products measure the ability to feel vibrations in the skin, and are used by healthcare providers to be able to adapt treatment or take preventive measures in the event of potential nerve damage. The company's customers mainly consist of diabetes clinics, hospitals, health centers and research institutes. Vibrosense Dynamics was founded in 2005 and is headquartered in Malmö.

Read more
Market cap
19.52M SEK
Turnover
9.54K SEK
Revenue
2.2M
EBIT %
-225.91 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release11/6/2025, 12:00 PM

VibroSense Dynamics announces delayed deliveries to China

Vibrosense Dynamics
Regulatory press release10/17/2025, 6:30 AM

VibroSense: Interim report 5 for the period 1 July 2025 - 30 September 2025

Vibrosense Dynamics
Regulatory press release9/9/2025, 9:18 AM

Newsletter - VibroSense Dynamics AB strengthens its organisation and prepares for launch in China

Vibrosense Dynamics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release8/1/2025, 11:14 AM

VibroSense: Obtains patent on Biomarker to predict the risk of getting nerve damage during cancer treatment with chemotherapy

Vibrosense Dynamics
Regulatory press release6/19/2025, 8:36 AM

VibroSense receives a formal NMPA certificate - three-year agreement with UMCare worth 3.74 million euros enters into force

Vibrosense Dynamics
Regulatory press release5/28/2025, 11:11 AM

VibroSense Dynamics enters research collaboration with Complutense University of Madrid

Vibrosense Dynamics
Regulatory press release5/21/2025, 12:21 PM

VibroSense Dynamics AB Receives NMPA Approval for VibroSense Meter® II in China

Vibrosense Dynamics
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.